Euroapi SAS banner

Intrinsic Value

The intrinsic value of Euroapi SAS (EAPIF) under the Base Case is 5.8114 USD per share. Compared with the current market price of 0.8446 USD, the stock appears Undervalued by 85% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

EAPIF Intrinsic Value
$5.8114
Undervaluation 85%
Intrinsic Value
Price $0.8446
E

EAPIF is cheaper than usual. This is its cheapest valuation in the past 4 years.

Monitor EAPIF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $4.65
Get notified when the price drops into your buy zone
Intrinsic Value $5.81
Margin of Safety 20% $4.65
Current Price $0.84
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to EAPIF

Fundamental Analysis

What Euroapi SAS Does

Pharmaceuticals Health Care

Euroapi SAS makes active pharmaceutical ingredients, or APIs, which are the main chemical substances used in medicines. It also helps drug makers develop and manufacture certain complex molecules. In simple terms, Euroapi sits in the middle of the pharmaceutical supply chain: it turns chemistry into the building blocks that other companies use to make finished drugs.

Headquarters
France FR
Employees
3 342
IPO date
May 6, 2022
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Euroapi SAS

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one EAPIF stock?

The intrinsic value for Euroapi SAS (EAPIF) under the Base Case is 5.8114 USD.

Is EAPIF stock undervalued or overvalued?

Compared with the current market price of 0.8446 USD, the stock appears Undervalued by 85% .

Back to Top